Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. / Nielsen, J D; Stoltenberg, Meredin; Siemsen, M; Juul, A; Pedersen, F; Madsen, J K.

In: Ugeskrift for Laeger, Vol. 152, No. 33, 1990, p. 2368-70.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Nielsen, JD, Stoltenberg, M, Siemsen, M, Juul, A, Pedersen, F & Madsen, JK 1990, 'Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse', Ugeskrift for Laeger, vol. 152, no. 33, pp. 2368-70.

APA

Nielsen, J. D., Stoltenberg, M., Siemsen, M., Juul, A., Pedersen, F., & Madsen, J. K. (1990). Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. Ugeskrift for Laeger, 152(33), 2368-70.

Vancouver

Nielsen JD, Stoltenberg M, Siemsen M, Juul A, Pedersen F, Madsen JK. Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. Ugeskrift for Laeger. 1990;152(33):2368-70.

Author

Nielsen, J D ; Stoltenberg, Meredin ; Siemsen, M ; Juul, A ; Pedersen, F ; Madsen, J K. / Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse. In: Ugeskrift for Laeger. 1990 ; Vol. 152, No. 33. pp. 2368-70.

Bibtex

@article{2771c7a726e94ecabd7fcf4254c9a507,
title = "Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En sp{\o}rgeskemaunders{\o}gelse",
abstract = "Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.",
author = "Nielsen, {J D} and Meredin Stoltenberg and M Siemsen and A Juul and F Pedersen and Madsen, {J K}",
year = "1990",
language = "Dansk",
volume = "152",
pages = "2368--70",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "33",

}

RIS

TY - JOUR

T1 - Anvendelse af fibrinolytika ved behandling af akut myokardieinfarkt i Danmark. En spørgeskemaundersøgelse

AU - Nielsen, J D

AU - Stoltenberg, Meredin

AU - Siemsen, M

AU - Juul, A

AU - Pedersen, F

AU - Madsen, J K

PY - 1990

Y1 - 1990

N2 - Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

AB - Questionnaires were sent to all Danish departments admitting patients with acute myocardial infarction (AMI) in order to investigate the attitudes of the departments to thrombolytic therapy in AMI. Two questionnaires were used: one with few questions which was answered by all 68 departments, and a more comprehensive questionnaire which was answered by 51 departments. The study shows that thrombolytic therapy now is use in all departments as opposed to 25% two years ago. In connection with introduction of thrombolytic therapy scientific studies are performed in 75% of the departments. In all departments, streptokinase (SK) is the drug of first choice and recombinant tissue plasminogen activator (rt-PA) is used in 2/3 of the departments in cases where SK-antibodies are suspected.

M3 - Tidsskriftartikel

VL - 152

SP - 2368

EP - 2370

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 33

ER -

ID: 48484597